SG10201901559SA - Retinal ganglion cells and progenitors thereof - Google Patents

Retinal ganglion cells and progenitors thereof

Info

Publication number
SG10201901559SA
SG10201901559SA SG10201901559SA SG10201901559SA SG10201901559SA SG 10201901559S A SG10201901559S A SG 10201901559SA SG 10201901559S A SG10201901559S A SG 10201901559SA SG 10201901559S A SG10201901559S A SG 10201901559SA SG 10201901559S A SG10201901559S A SG 10201901559SA
Authority
SG
Singapore
Prior art keywords
cells
retinal ganglion
progenitors
mature
methods
Prior art date
Application number
SG10201901559SA
Other languages
English (en)
Inventor
Wei Wang
Shi-Jiang Lu
Robert Lanza
Original Assignee
Astellas Inst For Regenerative Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Inst For Regenerative Medicine filed Critical Astellas Inst For Regenerative Medicine
Publication of SG10201901559SA publication Critical patent/SG10201901559SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/13—Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/33—Insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/42—Notch; Delta; Jagged; Serrate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG10201901559SA 2014-09-05 2015-09-05 Retinal ganglion cells and progenitors thereof SG10201901559SA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462046165P 2014-09-05 2014-09-05

Publications (1)

Publication Number Publication Date
SG10201901559SA true SG10201901559SA (en) 2019-03-28

Family

ID=55440432

Family Applications (3)

Application Number Title Priority Date Filing Date
SG10201901559SA SG10201901559SA (en) 2014-09-05 2015-09-05 Retinal ganglion cells and progenitors thereof
SG11201701709YA SG11201701709YA (en) 2014-09-05 2015-09-05 Retinal ganglion cells and progenitors thereof
SG10201912296RA SG10201912296RA (en) 2014-09-05 2015-09-05 Retinal ganglion cells and progenitors thereof

Family Applications After (2)

Application Number Title Priority Date Filing Date
SG11201701709YA SG11201701709YA (en) 2014-09-05 2015-09-05 Retinal ganglion cells and progenitors thereof
SG10201912296RA SG10201912296RA (en) 2014-09-05 2015-09-05 Retinal ganglion cells and progenitors thereof

Country Status (13)

Country Link
US (1) US20170274019A1 (pl)
EP (2) EP3189135B1 (pl)
JP (2) JP6778181B2 (pl)
KR (1) KR20170077117A (pl)
CN (1) CN107148276A (pl)
AU (2) AU2015311702A1 (pl)
CA (1) CA2960211A1 (pl)
ES (1) ES2883600T3 (pl)
IL (3) IL250924B (pl)
PL (1) PL3189135T3 (pl)
PT (1) PT3189135T (pl)
SG (3) SG10201901559SA (pl)
WO (1) WO2016037159A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI719277B (zh) * 2011-11-14 2021-02-21 美商安斯泰來再生醫藥協會 人類rpe細胞之醫藥組合物及其用途
ES2980659T3 (es) 2015-03-23 2024-10-02 Astellas Inst For Regenerative Medicine Ensayos mejorados de potencia de células de epitelio pigmentario retiniano (EPR) humano y progenitores de fotorreceptores
SG10201913250SA (en) 2015-08-18 2020-03-30 Astellas Inst For Regenerative Medicine Clinical formulations
WO2018119142A1 (en) 2016-12-21 2018-06-28 Amgen Inc. Anti-tnf alpha antibody formulations
WO2019078781A1 (en) 2017-10-17 2019-04-25 National University Of Singapore SYSTEMS AND METHODS FOR PRODUCING PHOTORECEPTOR PROGENITORS
WO2019152812A1 (en) * 2018-02-02 2019-08-08 University Of Maryland, Baltimore Methods of treating optic nerve diseases using neural progenitor cell growth factors
US11621058B2 (en) * 2018-02-08 2023-04-04 Ohio State Innovation Foundation Synthetic IHC-stained digital sides generated using artificial neural networks
PT4234024T (pt) * 2018-06-20 2026-01-21 Biolamina Ab Métodos e composições para produzir células do epitélio do pigmento da retina
KR102196069B1 (ko) 2019-04-17 2020-12-29 경북대학교 산학협력단 망막신경절세포의 분리방법 및 그에 의해 분리된 세포의 용도
CN112251408B (zh) * 2020-09-14 2022-04-12 郑州大学 视网膜神经节细胞的制备方法
CN114917367A (zh) * 2021-06-02 2022-08-19 中国科学院动物研究所 Lhx2在促进中枢系统神经元的损伤修复再生中的应用
CN115404219B (zh) * 2022-09-09 2023-10-27 中国医学科学院医学生物学研究所 一种树鼩视网膜神经节细胞的分离培养方法
CN117821382A (zh) * 2023-12-29 2024-04-05 广州赛莱拉干细胞科技股份有限公司 一种毛囊干细胞无血清培养基和培养方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2192916A4 (en) * 2007-08-23 2012-04-04 Univ Leland Stanford Junior MODULATION OF SYNAPTOGENESIS
JP5542686B2 (ja) * 2007-12-04 2014-07-09 プロテオバイオアクティブズ・ピーティーワイ・リミテッド 前駆細胞の保護およびその分化の調節
WO2011028524A1 (en) * 2009-08-24 2011-03-10 Wisconsin Alumni Research Foundation Substantially pure human retinal progenitor, forebrain progenitor, and retinal pigment epithelium cell cultures and methods of making the same
KR101268741B1 (ko) * 2009-10-06 2013-06-04 김지연 줄기세포를 망막세포로 분화시키는 방법
KR101712556B1 (ko) 2014-08-27 2017-03-08 서울대학교산학협력단 줄기세포를 망막신경절세포로 분화시키는 방법

Also Published As

Publication number Publication date
CA2960211A1 (en) 2016-03-10
PL3189135T3 (pl) 2021-12-20
EP3189135A1 (en) 2017-07-12
JP2020185004A (ja) 2020-11-19
IL250924B (en) 2020-10-29
JP6778181B2 (ja) 2020-10-28
SG10201912296RA (en) 2020-02-27
PT3189135T (pt) 2021-08-19
EP3922717A1 (en) 2021-12-15
KR20170077117A (ko) 2017-07-05
ES2883600T3 (es) 2021-12-09
AU2021240145A1 (en) 2021-10-28
JP2017532954A (ja) 2017-11-09
EP3189135B1 (en) 2021-06-02
WO2016037159A1 (en) 2016-03-10
JP7263293B2 (ja) 2023-04-24
IL277780A (en) 2020-11-30
IL285258A (en) 2021-09-30
US20170274019A1 (en) 2017-09-28
CN107148276A (zh) 2017-09-08
IL250924A0 (en) 2017-04-30
AU2015311702A1 (en) 2017-04-06
IL277780B (en) 2021-08-31
EP3189135A4 (en) 2018-04-25
SG11201701709YA (en) 2017-04-27

Similar Documents

Publication Publication Date Title
SG10201901559SA (en) Retinal ganglion cells and progenitors thereof
HK1222205A1 (zh) 由多能干细胞产生的光感受器和光感受器袓细胞
PH12019501557A1 (en) Bacillus isolates and uses thereof
WO2014100779A8 (en) Methods for production of platelets from pluripotent stem cells and compositions thereof
PH12020550660A1 (en) Cultivation of placenta to isolate exosomes
WO2014124087A8 (en) Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders
MY192824A (en) Compound targeting il-23a and tnf-alpha and uses thereof
GB2548740A (en) Methods for generation of podocytes from pluripotent stem cells and cells produced by the same
WO2014153346A8 (en) Engineering a heterogeneous tissue from pluripotent stem cells
SG10201808258SA (en) Improved methods for manufacturing adoptive cell therapies
MY185817A (en) Methods for production of oxygenated terpenes
PH12016500783A1 (en) Suspension and clustering of human pluripotent stem cells for differentation into pancreatic endocrine cells
MY201637A (en) Natural killer cells and ilc3 cells and uses thereof
SG10201809452RA (en) Cell culture compositions with antioxidants and methods for polypeptide production
MX2024001617A (es) Composiciones biofarmaceuticas.
EP4306174A3 (en) Composition for controlled ovarian stimulation
PH12020550871A1 (en) Process for the preparation of opicapone and intermediates thereof
MX2016011367A (es) Microorganismo recombinante que expresa analogos de avermectina y uso de los mismos.
PH12018502061A1 (en) Differentiation of pluripotent stem cells to intestinal midgut endoderm cells
MX2016000480A (es) Composiciones farmaceuticas de pancreatina de alta potencia.
IL246525B (en) Pomegranate derived cell culture and methods for preparing and using the same
TW201613953A (en) Process for the preparation of cyclic depsipeptides
WO2015171852A3 (en) Methods and compositions for non-cytotoxic stem cell transplantation
MX2021001981A (es) Metodos para preparar un poloxamero para usar en medio de cultivo celular.
MX2017014890A (es) Metodos de produccion de acetolactato-descarboxilasa (aldc).